Modafinil for multiple sclerosis fatigue: does it work? av Littleton, E, Hobart, J, Palace, J

Evidence-based guidelines for using the Short Form 36 in cervical dystonia. av Cano, S, Thompson, A, Bhatia, K, Fitzpatrick, R, Warner, T, Hobart, J

The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? av Cano, S, Warner, T, Thompson, A, Bhatia, K, Fitzpatrick, R, Hobart, J

Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. av Jenkinson, C, Hobart, J, Chandola, T, Fitzpatrick, R, Peto, V, Swash, M

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. av Cano, S, Hobart, J, Edwards, M, Fitzpatrick, R, Bhatia, K, Thompson, A, Warner, T

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. av Riazi, A, Hobart, J, Lamping, D, Fitzpatrick, R, Freeman, J, Jenkinson, C, Peto, V, Thompson, A

Design and rationale of the determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis (DELIVER-MS) t... av Ontaneda, D, Tallantyre, E, Nakamura, K, Planchon, S, Miller, D, Hersh, C, Chaudhry, B, Bale, C, Alvarez, E, Chataway, J, Craner, M, Freeman, L, Frost, N, Goldman, M, Hobart, J, Hunt, D, Hutton, G, Hyland, M, Joseph, F, Lily, O, Moses, H, Nicholas, J, Nicholas, R, Overell, J, Pearson, O, Pomeroy, I, Smith, A, Zabeti, A, Gerry, S, Gunzler, D, Coles, A, LaRocca, N, Gray, E, Cohen, J, Evangelou, N